Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 53608-75-6
- FDA UNII
- FQ3DRG0N5K
- Drug class
- Pancreatic enzyme replacement therapydigestive enzyme preparation
- Mechanism of action
- Supplies exogenous lipase, protease and amylase to replace pancreatic enzymes that are deficient in exocrine pancreatic insufficiency, supporting digestion of dietary fats, proteins and carbohydrates.
- Indications / reported uses
- Treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy or other conditions associated with pancreatic enzyme deficiency.
Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020725s003lbl.pdf · https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=pancrelipase
Identification source: PubChem substance record (SID 481101777; no discrete CID). Pancrelipase is a preparation of pancreatic enzymes. The mixture has no single molecular formula or molecular weight; PubChem identifies the substance record and the preparation CAS/UNII.